BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18813132)

  • 1. Policy considerations in designing a fragile X population screening program.
    Ross LF; Acharya K
    Genet Med; 2008 Oct; 10(10):711-3. PubMed ID: 18813132
    [No Abstract]   [Full Text] [Related]  

  • 2. Molloy v Meier and the expanding standard of medical care: implications for public health policy and practice.
    Burke T; Rosenbaum S
    Public Health Rep; 2005; 120(2):209-10. PubMed ID: 15842124
    [No Abstract]   [Full Text] [Related]  

  • 3. A majority of parents accept newborn screening for fragile X.
    Levenson D
    Am J Med Genet A; 2011 Sep; 155A(9):viii-ix. PubMed ID: 21853527
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethical and policy issues in newborn screening of children for neurologic and developmental disorders.
    Ross LF
    Pediatr Clin North Am; 2015 Jun; 62(3):787-98. PubMed ID: 26022175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on population screening for fragile X syndrome.
    Coffee B
    Genet Med; 2010 Jul; 12(7):411-2. PubMed ID: 20535018
    [No Abstract]   [Full Text] [Related]  

  • 6. Population screening for fragile-X syndrome.
    Bonthron D; Strain L
    Lancet; 1993 Mar; 341(8847):769-70. PubMed ID: 8095681
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis and prevention of fragile-X syndrome. From the family study to the population screening programme: eighteen years of activity.
    Giovannucci Uzielli ML; Guarducci S; Cecconi A; Lenzi S; Ricci U; Balestrieri C; Petrocelli P; Lapi E
    Acta Genet Med Gemellol (Roma); 1996; 45(1-2):303-8. PubMed ID: 8872054
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular genetic screening in cytogenetically normal mentally retarded males with manifestations of fragile X syndrome.
    Butler MG; Pratesi R; Vnencak-Jones CL
    Am J Med Genet; 1994 Jul; 51(4):315-6. PubMed ID: 7942993
    [No Abstract]   [Full Text] [Related]  

  • 9. A systematic review of population screening for fragile X syndrome.
    Hill MK; Archibald AD; Cohen J; Metcalfe SA
    Genet Med; 2010 Jul; 12(7):396-410. PubMed ID: 20548240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. You can build it ... but will they come?: the potential "expansion" of testing methodologies for fragile X syndrome.
    Potter NT
    J Mol Diagn; 2009 Jul; 11(4):279-80. PubMed ID: 19460939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing for fragile X gene mutations throughout the life span.
    Hagerman RJ; Hagerman PJ
    JAMA; 2008 Nov; 300(20):2419-21. PubMed ID: 19033593
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges in prenatal screening and counselling for fragile X syndrome.
    Mak AS; Leung KY
    Hong Kong Med J; 2017 Apr; 23(2):108-9. PubMed ID: 28387201
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and screening of fragile X syndrome: experiences in Taiwan.
    Lin SJ
    Acta Paediatr Taiwan; 2004; 45(2):67-8. PubMed ID: 15335112
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanded carrier screening and the law of unintended consequences: from cystic fibrosis to fragile X.
    Grody WW
    Genet Med; 2011 Dec; 13(12):996-7. PubMed ID: 22134443
    [No Abstract]   [Full Text] [Related]  

  • 15. The fragile-X syndrome: a growing gene causing familial intellectual disability.
    De Vries LB; Halley DJ; Oostra BA; Niermeijer MF
    J Intellect Disabil Res; 1994 Feb; 38 ( Pt 1)():1-8. PubMed ID: 8173220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of screening strategies for fragile X syndrome in the UK.
    Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
    Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.
    Archibald AD; Jaques AM; Wake S; Collins VR; Cohen J; Metcalfe SA
    Am J Med Genet A; 2009 Dec; 149A(12):2731-8. PubMed ID: 19938084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile X syndrome testing in the North West.
    Smith K; Chandler K; Hindley D; Ramsden SC
    Arch Dis Child; 2013 Mar; 98(3):239. PubMed ID: 23334255
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic evaluation of prenatal population screening for fragile X syndrome.
    Hollingsworth B; Harris A
    Community Genet; 2005; 8(2):68-72. PubMed ID: 15925881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ask the expert. Genetic testing for fragile X.
    Prows CA; Lovell AM
    J Soc Pediatr Nurs; 1998; 3(4):161-6. PubMed ID: 9884950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.